The initial success of Viagra undeniably revolutionized the drug landscape, but betting in companies primarily reliant on unbranded versions presents a uncertain picture. While early returns were impressive, the cessation of patents and the emergence of cheaper alternatives have weakened market share. Consequently, a thorough assessment of ongoing